Unblocked and Unbossed: How Novartis is Reimagining Medicine
As a leading international pharmaceutical company, Novartis is redefining its approach to developing and delivering innovative products. This initiative aims to tackle some of the most challenging diseases effectively. “We organize around four areas including Cardiovascular, Renal and Metabolic (CRM), Immunology, Neuroscience, and Oncology globally. In Taiwan, primarily cardiovascular and cancer are the key focus,…